sodium thiosulfate (DB-020) / Regeneron, Decibel Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sodium thiosulfate (DB-020) / Regeneron
ACTRN12620000182998: Phase 1b trial to investigate the prevention of hearing loss in cancer patients receiving cisplatin chemotherapy

Not yet recruiting
1/2
70
 
Decibel Therapeutics Australia Pty Ltd, Decibel Therapeutics Australia Pty Ltd
Hearing loss (ototoxicity from cisplatin medication)
 
 

Download Options